| Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia studied in …STUDIED_INderived13 of 13show fewer |
|---|
| → studied in | NCT02566304Phase 2 · completed Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 13 trials mapped (0 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00589316Phase 1 · terminated Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome · condition mapped ALIAS · 13 trials mapped (0 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00119366Phase 2 · terminated Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 13 trials mapped (0 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397813Phase 2 · completed Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ALIAS · 13 trials mapped (0 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012492Phase 2 · completed Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT · condition mapped ALIAS · 13 trials mapped (0 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008177Phase 1 · completed Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · condition mapped ALIAS · 13 trials mapped (0 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01165996Phase 1/Phase 2 · completed Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome · condition mapped ALIAS · 13 trials mapped (0 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01789255Phase 2 · completed Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies · condition mapped ALIAS · 13 trials mapped (0 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00988715Phase 1 · completed Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome · condition mapped ALIAS · 13 trials mapped (0 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462605Phase 2 · completed MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia · condition mapped ALIAS · 13 trials mapped (0 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104962Phase 1 · completed Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes · condition mapped ALIAS · 13 trials mapped (0 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00305773Phase 2 · completed Vorinostat in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 13 trials mapped (0 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005845Phase 1 · completed Tipifarnib in Treating Patients With Myelodysplastic Syndromes · condition mapped ALIAS · 13 trials mapped (0 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |